The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity
AbstractMultimodal imaging is commonly used in the management of patients with cancer. Imaging plays pivotal roles in the diagnosis, initial staging, treatment response assessment, restaging after treatment and the prognosis of many cancers. Indeed, it is difficult to imagine modern precision cancer care without the use of multimodal molecular imaging, which is advancing at a rapid pace with innovative developments in imaging sciences and an improved understanding of the complex biology of cancer. Cancer therapy often leads to undesirable toxicity, which can range from an asymptomatic subclinical state to severe end organ damage and even death. Imaging is helpful in the portrayal of the unwanted effects of cancer therapy and may assist with optimal clinical decision-making, clinical management, and overall improvements in the outcomes and quality of life for patients. View Full-Text
Share & Cite This Article
Jadvar, H. The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity. Diagnostics 2017, 7, 43.
Jadvar H. The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity. Diagnostics. 2017; 7(3):43.Chicago/Turabian Style
Jadvar, Hossein. 2017. "The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity." Diagnostics 7, no. 3: 43.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.